Source: Annual Congress 2011 - Cell biology of lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Beers, D. Jain, F. Blank, Y. Tomer, C. von Garnier (Philadelphia, United States Of America; Bern, Switzerland). Surfactant protein D is critical for local immunomodulation in the distal lung. Eur Respir J 2011; 38: Suppl. 55, 3886

Member's Comments

No comment yet.

Related content which might interest you: Surfactant protein D as a potential serum marker of pulmonary emphysema Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention Year: 2011 Surfactant pretreatment preserves lung function in ischemia-reperfusion-injury of the lung Source: Eur Respir J 2005; 26: Suppl. 49, 221s Year: 2005 Loss of structural integrity and function of surfactant protein D (SP-D) by cystic fibrosis- related proteases Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 Role of ABCA3 in paediatric interstitial lung disease associated with surfactant protein C gene mutations Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009 Translocation of TNF-α from the gut to the lung by VILI is reduced by exogenous surfactant therapy Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002 Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Surfactant protein D influences allergic immune responses Source: Eur Respir J 2003; 22: Suppl. 45, 194s Year: 2003 The role of vitamin D in regulating the severity and duration of murine lung injury Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013 HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level Source: International Congress 2018 – Orphan diseases in children Year: 2018 Oral presentation: Vitamin D binding protein is functionally important in airway infections Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Surfactant protein A (SP-A) and alveolar complement activation in patients at-risk for ARDS Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002 Lung function is improved by surfactant pre-treatment in ischemia-reperfusion-injury of the lung Source: Eur Respir J 2004; 24: Suppl. 48, 204s Year: 2004 Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population Source: Eur Respir J 2001; 18: 482-490 Year: 2001 Inhaled activated protein C protects mice from ventilator-induced lung injury Source: Annual Congress 2009 - Acute lung injury: biological mechanisms Year: 2009 Barrier-protective effects of activated protein C in human alveolar epithelial cells Source: Annual Congress 2013 –Experimental models in critical care Year: 2013 Surfactant protein A modulate bleomycin-induced lung injury in toll-like receptor 2 dependent pathway Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 LSC - 2019 - Surfactant protein SP-D to the rescue of NETosis and NET-induced lung surfactant inactivation Source: International Congress 2019 – Injury and repair: less is more Year: 2019